SOLARA ACTIVE PHARMA SCIENCES LIMITED — Major Shareholding Notification 2021

Oct 8, 2021

==> picture [205 x 82] intentionally omitted <==

Communication Address: Solara Active Pharma Sciences Limited Batra Centre No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : investors@solara.co.in www.solara.co.in

October 08, 2021

BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Listing Department Phiroze Jeeejeebhoy Towers Exchange Plaza, Bandra-Kurla Complex Dalal Street, Fort Bandar (East) Mumbai 400 001 Mumbai – 400 051 Scrip Code; 541540 Scrip Code: SOLARA

Dear Sir/ Madam,

Sub: Intimation under Regulation 31A of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR)

Approval received from BSE Limited and National Stock Exchange of India Limited for reclassification of shareholding from ‘Promoter Group’ to ‘Public’ Category’

Further to the application made by the Company on April 8, 2021 for reclassification of Sequent Scientific Limited from Promoter Group to Public category, please find attached approval mail dated October 7, 2021, from BSE Limited and letter dated October 7, 2021 from National Stock Exchange Limited approving the request for reclassification.

Consequent to the reclassification, the overall promoter holding as on date will be 39.53% as against 41.07 % prior to this reclassification.

We request you to take the above on record.

Thanking you, Yours faithfully,

For Solara Active Pharma Sciences Limited

S Digitally signed by S Muralikrishna Muralikrishna Date: 2021.10.08 15:14:57 +05'30'

S Murali Krishna Company Secretary & Compliance Officer

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942

==> picture [346 x 41] intentionally omitted <==

==> picture [207 x 68] intentionally omitted <==

==> picture [346 x 41] intentionally omitted <==

==> picture [207 x 28] intentionally omitted <==

==> picture [346 x 15] intentionally omitted <==

Ref: NSE/LIST/138

October 07, 2021

The Company Secretary

Solara Active Pharma Sciences Limited 201, Devavrata, Sector 17, Vashi, Navi Mumbai- 400703

Sub : Approval for Reclassification of Promoters under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Dear Sir/Madam,

This has reference to your application dated April 08, 2021 seeking Reclassification of Promoters under the provisions of Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Based on submissions made by the company, the Exchange is pleased to approve your application for reclassification of following Promoter as per the provisions of Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Sr. No. Name 1 SEQUENT SCIENTIFIC LIMITED

You are required to ensure that the event of reclassification shall be disclosed to the Exchange as a material event in accordance with the provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Yours faithfully,

For National Stock Exchange of India Ltd.

Charmi Dharod

Manager

CC: National Securities Depository Limited Central Depository Services Limited 4th Floor, Trade world, P.J.Towers, 28th Floor, Kamala Mills Compound, Dalal Street, Mumbai - 400 073 Senapati Bapat Marg., Lower Parel, Mumbai - 400 013

==> picture [144 x 41] intentionally omitted <==

Confidential

Abhinandhanan RS

Abhinandhanan RS
From:	Tanvi Patwardhan Tanvi.Patwardhan@bseindia.com
Sent:	07 October 2021 23:23
To:	Murali Krishna; Abhinandhanan RS
Cc:	Regulation 30
Subject:	Approval letter for reclassification application_Solara Active Pharma Sciences Ltd

CAUTION: This email has originated from outside of the organization. Do not click links or open attachments unless you recog

To,

The Company Secretary/ Compliance Officer

Solara Active Pharma Sciences Ltd

201, Devavrata, Sector 17, Vashi, Navi Mumbai, Maharashtra, 400703

Sub: Approval letter for Reclassification of Shareholders under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Dear Sir/Madam,

We refer to your application dated April 08, 2021 seeking Reclassification of Promoter Shareholders under the provisions of Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The Exchange is pleased to approve your application for Reclassification of Promoter Shareholders under the provisions of Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 based on submissions made by the company.

Entities mentioned in Annexure 1 shall be classified as public shareholders.

The summary of the Shareholding Pre-Reclassification & Post-Reclassification is as follows:

Quarter	Promoter holding	Promoter holding	Public Holding	Public Holding
	Shares Held	Percentage	Shares Held	Percentage
Pre-Reclassification				58.93
	1,47,55,793	41.07	2,11,73,974
Post-Reclassification	1,42,03,710	39.53	2,17,26,057	60.47

1

This email may be forwarded to the depositories and your RTA for necessary action at their end.

Encl. Annexure 1 - Details of Outgoing Promoters

Annexure 1 – Details of Outgoing Promoters

ANNEXURE	I
Sr.No.Name of the Outgoing Promoters	No. of shares	% Holding
1.Sequent Scientific Limited	5,52,083	1.54
TOTAL	5,52,083	1.54

Thanks and Regards, Tanvi Patwardhan Assistant Manager Listing Compliance BSE Limited, PJ Tower, Dalal Street, Mumbai – 400001 Phone (Direct): 022728148

World’s Fastest Exchange with A Speed of 6 Microseconds

This mail is classified as 'BSE - PUBLIC' by Tanvi.Patwardhan on October 07, 2021 at 23:22:58.

DISCLAIMER : The contents of this message may be legally privileged and confidential and are for the use of the intended recipient(s) only. It should not be read, copied and used by anyone other than the intended recipient(s). If you have received this message in error, please immediately notify the sender, preserve its confidentiality and delete it. Before opening any attachments please check them for viruses and defects. DISCLAIMER : The contents of this message may be legally privileged and confidential and are for the use of the intended recipient(s) only. It should not be read, copied and used by anyone other than the intended recipient(s). If you have received this message in error, please immediately notify the sender, preserve its confidentiality and delete it. Before opening any attachments please check them for viruses and defects.

2